BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian FDA considers adding a dozen peptides to its bulk drug compounding list RAPS In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The Pharmacology of Longevity: Peptide Edition (Part 1)